Jung, J.S.; Lee, J.E.; Lee, J.; Huh, S.O.

May 8, 2024

Jung, J.S.; Lee, J.E.; Lee, J.; Huh, S.O.; Kim, H.S.; Jung, K.C.; Cho, J.Y.; Nam, J.S.; Suh, H.W.; et al. Therapeutic effects of lysophosphatidylcholine in experimental sepsis. Nat. Med. 2004, ten, 16167. 20. Rolin, J.; Maghazachi, A.A. Implications of chemokines, chemokine receptors, and inflammatory lipids in atherosclerosis. J. Leukoc. Biol. 2014, 95, 57585. 21. Benitez, S.; Camacho, M.; Arcelus, R.; Vila, L.; Bancells, C.; Ordonez-Llanos, J.; Sanchez-Quesada, J.L. Improved lysophosphatidylcholine and non-esterified fatty acid content material in LDL induces chemokine release in endothelial cells. Partnership with electronegative LDL. Atherosclerosis 2004, 177, 29905. 22. Rolin, J.; Al-Jaderi, Z.; Maghazachi, A.A. Oxidized lipids and lysophosphatidylcholine induce the chemotaxis and intracellular calcium influx in natural killer cells. Immunobiology 2013, 218, 87583. 23. Nagy, L.; Tontonoz, P.; Alvarez, J.G.; Chen, H.; Evans, R.M. Oxidized LDL regulates macrophage gene expression through ligand activation of PPAR. Cell 1998, 93, 22940. 24. Huang, J.Shogaol Purity & Documentation T.; Welch, J.S.; Ricote, M.; Binder, C.J.; Willson, T.M.; Kelly, C.; Witztum, J.L.; Funk, C.D.; Conrad, D.; Glass, C.K. Interleukin-4-dependent production of PPAR-gamma ligands in macrophages by 12/15-lipoxygenase. Nature 1999, 400, 37882. 25. Schild, R.L.; Schaiff, W.T.; Carlson, M.Nafcillin sodium Cancer ; Cronbach, E.PMID:24182988 J.; Nelson, D.M.; Sadovsky, Y. The activity of PPAR gamma in primary human trophoblasts is enhanced by oxidized lipids. J. Clin. Endocrinol. Metabolism 2002, 87, 1105110. 26. Obinata, H.; Hattori, T.; Nakane, S.; Tatei, K.; Izumi, T. Identification of 9-hydroxyoctadecadienoic acid and also other oxidized absolutely free fatty acids as ligands in the G protein-coupled receptor G2A. J. Biol. Chem. 2005, 280, 406760683. 27. Waddington, E.I.; Croft, K.D.; Sienuarine, K.; Latham, B.; Puddey, I.B. Fatty acid oxidation merchandise in human atherosclerotic plaque: An analysis of clinical and histopathological correlates. Atherosclerosis 2003, 167, 11120. 28. Waddington, E.; Sienuarine, K.; Puddey, I.; Croft, K. Identification and quantitation of distinctive fatty acid oxidation products in human atherosclerotic plaque utilizing high-performance liquid chromatography. Anal. Biochem. 2001, 292, 23444.Toxins 2014,29. Witte, O.N.; Kabarowski, J.H.; Xu, Y.; Le, L.Q.; Zhu, K. Retraction. Science 2005, 307, 206. 30. Frasch, S.C.; Zemski-Berry, K.; Murphy, R.C.; Borregaard, N.; Henson, P.M.; Bratton, D.L. Lysophospholipids of distinct classes mobilize neutrophil secretory vesicles and induce redundant signaling by way of G2A. J. Immunol. 2007, 178, 6540548. 31. Maghazachi, A.A. Intracellular signaling events in the major edge of migrating cells. Int. J. Biochem. Cell Biol. 2000, 32, 93143. 32. Han, K.H.; Chang, M.K.; Boullier, A.; Green, S.R.; Li, A.; Glass, C.K.; Quehenberger, O. Oxidized LDL reduces monocyte CCR2 expression through pathways involving peroxisome proliferator-activated receptor gamma. J. Clin. Invest. 2000, 106, 79302. 33. Barlic, J.; Zhang, Y.; Foley, J.F.; Murphy, P.M. Oxidized lipid-driven chemokine receptor switch, CCR2 to CX3CR1, mediates adhesion of human macrophages to coronary artery smooth muscle cells by way of a peroxisome proliferator-activated receptor -dependent pathway. Circulation 2006, 114, 80719. 34. Zaguri, R.; Verbovetski, I.; Atallah, M.; Trahtemberg, U.; Krispin, A.; Nahari, E.; Leitersdorf, E.; Mevorach, D. Danger’ impact of low-density lipoprotein (LDL) and oxidized LDL on human immature dendritic cells. Cli.